Dallas, Texas 04/15/2014 (FINANCIALSTRENDS) – DATATRAK International, Inc.(OTCMKTS:DTRK) has for a long time now been offering a range of technology and services related services solutions. The main line of services are essentially in the eClinical solutions niche with a range of clinical trials being conducted.
DATATRAK International, Inc. (OTCMKTS:DTRK) offers it services to review, collect, transmit as well as store clinical data of the trials in digital format only.
DATATRAK International, Inc. (OTCMKTS:DTRK) has a market cap of $10.09 million. This stock has a trading stock price of $7.40 low and $7.60 low. The 52 week trading high for the company is $12.60 while low point is $4.86. EPS is -0.33. Outstanding shares by the company are 1.36 million. Beta is 0.28.
DATATRAK International, Inc. (OTCMKTS:DTRK) at the end of trading session, showed a fall of 3.90%, a drop of 0.30, closing the session at $7.40.
DATATRAK International, Inc. (OTCMKTS:DTRK) customers and clients are typically from the clinical trial management systems as well as the electronic data capture services. The Electronic data capture, which includes medical coding as well as other digitized product services too are part of DATA TRAK’s repertoire.
The company is also known to have launched a series of programs which are aimed at developing inventory for drug management. A special aspect of this range is the randomization as well as drug inventory management, called as IRT.
DTRK has been serious with clinical trial design and trading and will look at updating programs which will now offer mid-study changes as well as clinical file repository of data and study assets.
Additionally, DTRK is well noted for the various kinds of projects it develops- ranging from content and training to work-based systems. The Mayfield Heights based provider of technology though in showing a downward slide in recent weeks, does have the arsenal to scale back to original heights, it remains a matter of time before it does so.